Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
E-pub ahead of print

Response to: 'Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4: possible fallout on non-medical switching' by Cantini and Benucci

Research output: Contribution to journalComment/debateResearchpeer-review

View graph of relations
Original languageEnglish
JournalAnnals of the Rheumatic Diseases
ISSN0003-4967
DOIs
Publication statusE-pub ahead of print - 2019

ID: 56069716